Industry NewsLonza and Renova Therapeutics Announce Manufacturing Agreement for Clinical Supply of RT-100 Gene Therapy
Product NewsLonza Introduces Integrated HT Nucleofector™ System for High-Throughput Non-Viral CRISPR and RNAi Screens in Hard-to-Transfect Cells
Product NewsFirst Glimpse of Lonza’s Next-Generation Automation Solutions for Endotoxin Detection – at SLAS2016
Product NewsLonza Further Strengthens QC Insider™ Toolbox with Launch of e-Learning Modules for Endotoxin Testing
Industry NewsLonza Announces Second Global Endotoxin Testing Summit – and Another Opportunity to “Flip” Crabs